Trial Profile
Immune Responses in Preterm and Full-Term Infants Following Live, Attenuated Influenza Vaccination.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 12 Oct 2012 Status changed from recruiting to completed.
- 11 Aug 2011 Planned end date changed from May 2011 to May 2012 as reported by ClinicalTrials.gov.
- 15 Sep 2010 New trial record